PATHOPHYSIOLOGICAL REASONING OF THE EFFICIENCY OF ANTI-ANGIOGENIC THERAPY IN THE RETINAL VEIN OCCLUSION BY THE COHERENT EYE TOMOGRAPHY

Aim. The main aim of our research is to study the effectiveness of anti-VEGF therapy in the treatment of retinal vein occlusions.

Materials and methods. The study included 124 patients aged between 23 to 66, an average of 54.3±8.9 years old who were on an outpatient and inpatient treatment in the ophthalmologic department of the V.K. Gusak Institute of Emergency and Reconstructive Surgery from 2011 to 2016. We have formed two groups. The comparison group included 66 patients who received standard therapy in the form of local anticoagulant and anti-edematous therapy, disaggregants. To improve microcirculation and with a decongestant purpose, rheopolyglucin was administered intravenously, and intramuscular injections of actovegin were prescribed with an antihypoxic purpose. With edema of the macula and the development of newly formed vessels – laser coagulation, intravitreal or subtenon introduction of trimacionolone. The main group included 58 patients who, in addition to standard therapy, were given the drug Eilia (aflibercept) intravitreally 2 mg in 0.05 ml. Treatment with aflibercept for intravitreal injections started with one injection once a month for the next five months, with a further transition to one injection every two months, with no monitoring required between the injections.

Results. When post-thrombotic neovascular glaucoma occurred, the concentration of TGFα in the lacrimal fluid increased by 1.7, and TGFβ by 28-fold. When the branch of the central vein of the retina is occluded according to the ischemic type, the systolic and diastolic blood flow velocity in the retina decreases. With coherent optical tomography with the function of angiography, admission in both groups showed significant macular edema, non-perfusion zones of the retina, a decrease in the density of the capillary network in the inner layers of the retina in angio-OCT, and 3 patients with angio-OCT visualized newly formed vessels in the nonperfusion zone.

Conclusion. In the group with the use of anti-angiogenic drugs, earlier restoration of the visual fields and reduction of neoangiogenesis were noted.

1. Rogers S., McIntosh R.L., Cheung N. et al. The prevalence of retinal vein occlusion: poolled data from population studies from the United States, Europe, Asia, and Australia. Ophthalmology. 2010;. 117(2), P. 313-319.

2. Zakharov V.D., Kashtan O.V., Solomin V.A., Osokin I.G. Mediumterm results of surgical treatment of outcomes of central retinal vein thrombosis based on minimally invasive (25G) vitrectomy with endolaser induction of chorioretinal venous anastomoses. Bulletin of Orenburg State University. 2011; 14(133): 148-150. (In Russ., English abstract).

3. Boriskina L.N., Potapova V.N., Melikhova I.A., Polyakova V.R. Intravitreal administration of Lucentis in combination with laser coagulation of the retina in the treatment of macular edema due to thrombosis of the branch of the central vein of the retina. Bulletin of Tambov University. Series: Natural and technical sciences. 2014; 19(4): 1092-1093. (In Russ., English abstract).

4. Avetisova S.E., Egorova EA, Moshetova LK, Neroeva VV, Takhchidi Kh.P. Natsionalnoe rukovodstvo po oftalmologii [National guidelines on ophthalmology]. Moscow: 2008. 599-609 p. (In Russ).

5. Branch Vein Occlusion Study Group. Argon laser phothocoagulation for macular edema in branch vein occlusion. Am. J. Ophthalmology. 1994; 98: 271-282.

6. Green W.R., Chan C.C., Hutchins G.M., Terry J.M. Central retinal vein occlusion: a prospective histopathologic study of 29 eyes in 28 cases. Trans Am Ophthalmol Soc. 1981; 79: 371-422.

7. Wolf S, Wolf-Schnurrbusch U. Spectral-domain optical coherence tomography use in macular diseases: a review. Ophthalmologica. 2010; 224: 333-340.

8. Liu X., Kirby M., Zhao F. Motion analysis and removal in intensity variation based OCT angiography. Biomed Opt Express. 2014; 5: 3833-3847.

9. Rodolfo M., Luca D. A., Silvio D. S., et al. Optical Coherence Tomography Angiography in Retinal Vascular Diseases and Choroidal Neovascularization. Journal of Ophthalmology. 2015, Article ID 343515, 8 pages. DOI:10.1155/2015/343515.

10. Zakharov V.D., Kashtan O.V., Osokin I.G. Laser and surgical treatment of outcomes of thrombosis of retinal veins. Modern technologies in medicine. 2012; 1: 101-107. (In Russ.).

11. Ip M.S., Gottlieb J.L., Kahana A. et al. Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion. Arch of Ophthalmol. 2004; 122: 1131-1136.

12. Batioglu F., Ozmert E., Akmese E. Two-year results of intravitreal triamcinolone acetonide injection for the treatment of macular edema due to central retinal vein occlusion. Ann Ophthalmol. 2007; 39(4): 307-311.

13. Ramchandran R.S., Fekrat S., Stinnett S.S., Jaffe G.J. Fluocinolone acetonide sustained drug delivery device for chronic central retinal vein occlusion: 12-month results. Am J Ophthalmol. 2008; 146: 285-291.

14. Mykhaylichenko V.Yu., Kubyshkin A.V., Fomochkina I.I., Anisimova L.V., Samarin S.A. Experimental induction of reparative morphogenesis and adaptive reserves in the ischemic myocardium using multipotent mesenchymal bone marrow-derived stem cells. Pathophysiology. 2016; 23(2): 95-104. DOI:10.1016/j.pathophys.2016.04.002

15. Mykhaylichenko V.Yu. Ivashchenko A.S. Pathophysiological factors predicting the course of venous thrombosis of the retina of the eye. Taurian medical and biological bulletin. 2014; 2(66): 94-98. (In Russ., English abstract).

16. Mykhaylichenko V.Yu., Ivashchenko A.S., Churilov A.V., Ivantsova N.L. Clinical basis for the use of anti-angiogenic therapy for thrombosis of the retina of the eye in humans. Taurian medical and biological bulletin, 2014; 4: 65-69. (In Russ., English abstract).

17. Rouvas A., Petron P., Ntouraki A. et al. Intravitreal ranibizumab (Lucentis) for branch retinal vein occlusion – induced macular edema: nine-month results of prospective study. Retina. 2010; 30(6): 893-902.